UK MHRA to float device cost coverage plans for 2016
This article was originally published in Clinica
Executive Summary
A steady but constant reduction in resource allocation for the medical device regulatory work carried out by the UK’s Medicines and Healthcare Products Regulatory Agency has seen the organization’s device staff deploy efficiency strategies and proactive methods of coping with regulatory demands. The MHRA’s device budget has dropped from around £13m in 2009/10 to £8m ($12.6m) currently.